STAT Plus: It’s only test tubes and mice, but Rubius Therapeutics hails first new data on red blood cell-derived cancer drugs
RUBY WALLAU FOR STAT
The results come from test tubes and mice, but Rubius says they show that genetically augmenting red blood cells to stimulate the immune system is possible.
No hay comentarios:
Publicar un comentario